Chongqing Peg-bio Biopharm Co., Ltd.

This early study tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who had low platelets from chemotherapy. The goal was to see if a single shot before chemo is safe and can help prevent dangerously low platelet counts. Results will guide future research on…

This early-stage study tested whether FT1 is safe in 60 healthy adults aged 18 to 45. Participants received one or more injections of FT1 or a placebo. Researchers monitored side effects and measured how the drug behaves in the body.